Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6-18 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1/2 trial. (doi.org)

Authors: Idoko OT … Dhingra MS Journal: Lancet Microbe Published: 2026-10-13 DOI: https://doi.org/10.1016/j.lanmic.2026.101447